1)  VM-26
替尼泊甙
1.
The influences of Actinomycin D and VM-26 on proliferation in rat glioma cell line C_6;
放线菌素D和替尼泊甙对大鼠胶质瘤细胞增殖影响的实验研究
2.
Objective To study the therapeutic effect of actimomycin D (ACTD) and VM-26 on rat C6 glioma invivo.
目的研究放线菌素D(ACTD)、替尼泊甙(VM-26)对大鼠胶质瘤细胞增殖的体内治疗效果。
3.
Objective To investigate the curative effect of intravenous chemotherapy with BVD(BCNU+VM-26+DDP) in treating brain gliomas after surgical excision.
目的探讨脑胶质瘤术后应用BVD方案(卡氮芥+替尼泊甙+顺铂)静脉化疗的临床疗效。
2)  VM-26
维埃坶26
3)  VM-26
表鬼臼毒噻吩糖甙
1.
Objective In order to elucidate the mechanism of resistance and apoptosis of Nicardipine (NCDP) combined with epipodophyllotoxin thenylidine (VM-26) reverse C6/VM-26.
目的为了阐明钙离子拮抗剂尼卡地平与表鬼臼毒噻吩糖甙(威猛VM26)联合作用逆转C6/VM26耐药、诱导胶质瘤细胞凋亡发生的机制。
4)  VM-26
鬼臼噻吩甙
1.
Objective To research feasibility of intraperitoneal administration of VM-26,the pharmacokinetics in the plasma of mice,the concentration and distribution of VM-26 in liver?kidneys and intestinal wall were determined.
目的 :测定VM - 2 6(鬼臼噻吩甙 )腹腔内应用后的血浆药代动力学参数 ,肝脏、肾脏、肠壁的药物浓度分布 ,为治疗卵巢癌腹腔化疗提供理论依据。
5)  VM-26
VM-26
1.
Effect of VM-26 on BT325 in Vitro;
VM-26对体外培养癌细胞BT325的抑制实验
6)  VM-26
威猛
1.
Clinical Analysis of Radiotherapy Associated with VM-26 and DDP Chemotherapy of 23 Cases with Cerebral Metastatic Carcinoma;
威猛加顺铂化疗配合放射治疗脑转移癌23例临床分析
参考词条
补充资料：替尼泊甙
分子式：C32H32O13S
分子量：暂无
CAS号：29767-20-2

性质：暂无

制备方法：暂无

用途：用于白血病、恶性淋巴瘤、神经母细胞瘤、膀胱癌和小细胞肺癌。

说明：补充资料仅用于学习参考，请勿用于其它任何用途。